RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence
An Assessment of the Impact of Motivational Interviewing Via Glaucoma Educator on Glaucoma Treatment Adherence and Persistence
2 other identifiers
interventional
201
1 country
2
Brief Summary
The investigators are studying motivational interviewing (MI). MI is a counseling method to help people adopt healthy behaviors. The investigators will test whether MI improves patients' accurate use of glaucoma eye drops. The investigators will train eye clinic staff called glaucoma educators to use MI. Up to 250 patients at 3 clinics will be recruited. All patients will receive their usual eye care. Based on chance, some patients will also be supported by a glaucoma educator. The groups will be compared on medication adherence using micro-electro-mechanical system(MEMS). MEMS are electronic bottle caps that track when a medication bottle is opened. Patients will be aware that their medication use is tracked. The groups will also be compared on treatment value, outcomes, and cost. The investigators will also collect data on variables that may predict medication adherence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2011
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 2, 2011
CompletedFirst Posted
Study publicly available on registry
August 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedOctober 1, 2015
September 1, 2015
1.8 years
August 2, 2011
September 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Outcomes - MEMS-based Medication Adherence and Persistence:
Compare adherence and persistence between the intervention and control groups. (Medication Event Monitoring Systems)that record the date and time a pill bottle is opened we are evaluating the percentage of prescribed doses taken during ain one-week intervals, but will augment it by also considering a more fine-grained percentage of prescribed doses taken in required dosing window (defined as within 3 hours before or after the scheduled time) as a second primary outcome measure.
1 month
Secondary Outcomes (1)
Counselor-Rated Medication Adherence
1 Month
Study Arms (3)
motivational interviewing
EXPERIMENTAL3 phone and 3 in person counseling support sessions with glaucoma educator
reminder calls
ACTIVE COMPARATORbehavioral: three phone calls to remind patients to take their eye drops
standard care
NO INTERVENTIONstandard care for glaucoma
Interventions
reminder phone calls
Eligibility Criteria
You may qualify if:
- community-dwelling adults with primary or secondary open-angle glaucoma, and
- a current prescription for monotherapy topical glaucoma medication.
You may not qualify if:
- patient-reported inability to administer eye drops that cannot be addressed successfully through in-person instruction at the clinic,
- cognitive impairment at a level that would in the judgment of the referring physician interfere with study participation,
- referring physician's determination that glaucoma surgery is likely within the next 6 months,
- any active medical, psychological, or substance use disorder that would in the referring physician's judgment significantly interfere with study participation (e.g., comorbid congestive heart failure (CHF) resulting in a recent hospitalization; active psychosis due to uncontrolled bipolar disorder; etc.), or
- no visual field test within the past 6 months (data required for the randomization approach described below).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Denverlead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (2)
Lions Eye Institute, UC Denver
Aurora, Colorado, 80045, United States
Devers Eye Institute
Portland, Oregon, 97210, United States
Related Publications (1)
Cook PF, Schmiege SJ, Mansberger SL, Kammer J, Fitzgerald T, Kahook MY. Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med. 2015 Feb;49(1):29-39. doi: 10.1007/s12160-014-9641-8.
PMID: 25248302DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malik Kahook, MD
Lions Eye Inst. UC Denver
- PRINCIPAL INVESTIGATOR
Paul F Cook, Ph.D
UC Denver, College of Nursing
- PRINCIPAL INVESTIGATOR
Jeffery Kammer, MD
Vanderbilt University- Opthamology
- PRINCIPAL INVESTIGATOR
Steve Mansberger, MD
Devers Eye Inst. Oregon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2011
First Posted
August 4, 2011
Study Start
April 1, 2011
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
October 1, 2015
Record last verified: 2015-09